Page 10 - Base Shelf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article VAUGHAN, ON, April 12, 2021 /PRNewswire/ - GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) ("GFL" or the "Company") today announced that certain entities affiliated with BC Partners Advisors L.P., Ontario Teachers' Pension Plan Board, GIC Private Limited and HPS Investment Partners, LLC (collectively, the "Selling Shareholders"), have entered into an agreement with BMO Capital Markets, RBC Capital Markets and Scotiabank (collectively, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase on a bought deal basis an aggregate of 17,5...

Denison Announces Funding of Project Finance Initiative Involving Strategic Acquisition of Physical Uranium NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES  Denison Mines Corp. is pleased to announce that it has entered into an agreement with Cantor Fitzgerald Canada Corporation as lead underwriter and sole book-runner, on behalf of themselves and a syndicate of underwriters under which the … /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUB...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES  Denison Mines Corp. is pleased to announce that it has closed its bought deal private placement of common shares that qualify as "flow-through shares" for purposes of the Income Tax Act previously announced on February 11, 2021 . View ...

ESSA Pharma Announces Exercise of Option in Connection with Recently Completed $130 Million Financing News provided by Share this article Share this article VANCOUVER, BC and HOUSTON, March 4, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the underwriters have exercised their option (the "Option") to purchase an additional 724,637 common shares in the capital of the Company (the "Common Shares"), in connection with the Com...

ESSA Pharma Announces Pricing of Public Offering of Common Shares News provided by Share this article Share this article VANCOUVER, BC and HOUSTON, Feb. 17, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the pricing of an underwritten public offering of 4,830,918 common shares at a public offering price of $27.00 per share, before underwriting discounts, for an aggregate offering of approximately $130.4 million (the "Offering"). ...